
Opinion|Videos|November 14, 2023
Rectal Separation for Prostate Cancer Radiation Therapy: Clinical Data on Barrigel and BioProtect
The Phase 3 trials for the Barrigel and BioProtect rectal spacers demonstrated a dosimetric advantage and reduced rectal toxicity similar to SpaceOAR, but data on long-term toxicity and patient-reported outcomes is still needed to fully evaluate the newer spacers.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Permanent J code for mitomycin for intravesical solution now in effect
2
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
3
Real-World Evidence in mCSPC Management
4
FDA updates in urology: December 2025
5




















